关注
Evangelos Terpos
标题
引用次数
引用次数
年份
International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma
SV Rajkumar, MA Dimopoulos, A Palumbo, J Blade, G Merlini, MV Mateos, ...
The lancet oncology 15 (12), e538-e548, 2014
50732014
International Myeloma Working Group consensus criteria for response and minimal residual disease assessment in multiple myeloma
S Kumar, B Paiva, KC Anderson, B Durie, O Landgren, P Moreau, ...
The lancet oncology 17 (8), e328-e346, 2016
25502016
Hematological findings and complications of COVID‐19
E Terpos, I Ntanasis‐Stathopoulos, I Elalamy, E Kastritis, TN Sergentanis, ...
American journal of hematology 95 (7), 834-847, 2020
21412020
Osteonecrosis of the jaw in cancer after treatment with bisphosphonates: incidence and risk factors
A Bamias, E Kastritis, C Bamia, LA Moulopoulos, I Melakopoulos, ...
J Clin Oncol 23 (34), 8580-7, 2005
16112005
Widespread occurrence of the JAK2 V617F mutation in chronic myeloproliferative disorders
AV Jones, S Kreil, K Zoi, K Waghorn, C Curtis, L Zhang, J Score, R Seear, ...
Blood 106 (6), 2162-2168, 2005
11702005
Multiple myeloma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
P Moreau, J San Miguel, P Sonneveld, MV Mateos, E Zamagni, ...
Annals of oncology 28, iv52-iv61, 2017
8482017
Geriatric assessment predicts survival and toxicities in elderly myeloma patients: an International Myeloma Working Group report
A Palumbo, S Bringhen, MV Mateos, A Larocca, T Facon, SK Kumar, ...
Blood, The Journal of the American Society of Hematology 125 (13), 2068-2074, 2015
7812015
Multiple myeloma: EHA-ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
MA Dimopoulos, P Moreau, E Terpos, MV Mateos, S Zweegman, G Cook, ...
Hemasphere 5 (2), e528, 2021
6282021
Reduction of osteonecrosis of the jaw (ONJ) after implementation of preventive measures in patients with multiple myeloma treated with zoledronic acid
MA Dimopoulos, E Kastritis, C Bamia, I Melakopoulos, D Gika, M Roussou, ...
Annals of Oncology 20 (1), 117-120, 2009
5792009
Renal impairment in patients with multiple myeloma: a consensus statement on behalf of the International Myeloma Working Group
MA Dimopoulos, E Terpos, A Chanan-Khan, N Leung, H Ludwig, ...
Journal of clinical oncology 28 (33), 4976-4984, 2010
5362010
Organ-specific manifestations of COVID-19 infection
M Gavriatopoulou, E Korompoki, D Fotiou, I Ntanasis-Stathopoulos, ...
Clinical and experimental medicine 20, 493-506, 2020
5322020
Soluble receptor activator of nuclear factor κB ligand–osteoprotegerin ratio predicts survival in multiple myeloma: proposal for a novel prognostic index
E Terpos, R Szydlo, JF Apperley, E Hatjiharissi, M Politou, J Meletis, ...
Blood 102 (3), 1064-1069, 2003
5072003
Role of 18F-FDG PET/CT in the diagnosis and management of multiple myeloma and other plasma cell disorders: a consensus statement by the International Myeloma Working Group
M Cavo, E Terpos, C Nanni, P Moreau, S Lentzsch, S Zweegman, ...
The lancet oncology 18 (4), e206-e217, 2017
4912017
The effect of prolonged administration of hydroxyurea on morbidity and mortality in adult patients with sickle cell syndromes: results of a 17-year, single-center trial (LaSHS)
E Voskaridou, D Christoulas, A Bilalis, E Plata, K Varvagiannis, ...
Blood, The Journal of the American Society of Hematology 115 (12), 2354-2363, 2010
4902010
Personalized therapy in multiple myeloma according to patient age and vulnerability: a report of the European Myeloma Network (EMN)
A Palumbo, S Bringhen, H Ludwig, MA Dimopoulos, J Bladé, MV Mateos, ...
Blood, The Journal of the American Society of Hematology 118 (17), 4519-4529, 2011
4652011
Osteonecrosis of the jaw in patients with multiple myeloma treated with bisphosphonates: evidence of increased risk after treatment with zoledronic acid
MA Dimopoulos, E Kastritis, A Anagnostopoulos, I Melakopoulos, D Gika, ...
haematologica 91 (7), 968-971, 2006
4652006
International Myeloma Working Group recommendations for the treatment of multiple myeloma–related bone disease
E Terpos, G Morgan, MA Dimopoulos, MT Drake, S Lentzsch, N Raje, ...
Journal of clinical oncology 31 (18), 2347, 2013
4452013
International Myeloma Working Group recommendations for the diagnosis and management of myeloma-related renal impairment
MA Dimopoulos, P Sonneveld, N Leung, G Merlini, H Ludwig, E Kastritis, ...
Journal of Clinical Oncology 34 (13), 1544-1557, 2016
4432016
Role of magnetic resonance imaging in the management of patients with multiple myeloma: a consensus statement
MA Dimopoulos, J Hillengass, S Usmani, E Zamagni, S Lentzsch, ...
Journal of Clinical Oncology 33 (6), 657-664, 2015
4212015
Incidence, risk factors and management of osteonecrosis of the jaw in patients with multiple myeloma: a single‐centre experience in 303 patients
K Zervas, E Verrou, Z Teleioudis, K Vahtsevanos, A Banti, D Mihou, ...
British journal of haematology 134 (6), 620-623, 2006
4142006
系统目前无法执行此操作,请稍后再试。
文章 1–20